Editorial
doi: 10.1056/NEJM199602153340710.
Anemia, dialysis, and dollars
- PMID: 8552151
- DOI: 10.1056/NEJM199602153340710
Item in Clipboard
Editorial
Anemia, dialysis, and dollars
N Engl J Med.
.
No abstract available
Comment on
-
The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.N Engl J Med. 1996 Feb 15;334(7):420-5. doi: 10.1056/NEJM199602153340702. N Engl J Med. 1996. PMID: 8552143
Similar articles
-
The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.Contrib Nephrol. 1990;78:24-36; discussion 37. Contrib Nephrol. 1990. PMID: 2225841 Review. No abstract available.
-
Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.Transplant Proc. 1991 Apr;23(2):1831-2. Transplant Proc. 1991. PMID: 2053169 Review. No abstract available.
-
Erythropoietin for anemia of renal failure in sickle cell disease.N Engl J Med. 1991 May 9;324(19):1369-70. doi: 10.1056/NEJM199105093241916. N Engl J Med. 1991. PMID: 1759999 Clinical Trial. No abstract available.
-
[The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].Urol Nefrol (Mosk). 1990 Nov-Dec;(6):69-70. Urol Nefrol (Mosk). 1990. PMID: 2089771 Review. Russian. No abstract available.
-
Recombinant erythropoietin. The effect of the marketplace on socialized patient care.ASAIO J. 1993 Apr-Jun;39(2):85-6. ASAIO J. 1993. PMID: 8324265 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
